Brian Gardner
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Cannabis and Cannabinoid Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
- Pharmacology 11
- Inflammatory mediators and NSAID effects 8
- Cannabis and Cannabinoid Research 3
- Co-authors
- Sherven Sharma (18 shared papers)Steven M. Dubinett (20 shared papers)Li Zhu (9 shared papers)Raj K. Batra (7 shared papers)Karen L. Reckamp (9 shared papers)Marina Stolina (2 shared papers)Ying Lin (2 shared papers)Patrice W. Miller (2 shared papers)
- Journals
- The Journal of Immunology (5 papers)Journal of Thoracic Oncology (2 papers)Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Brian Gardner
27 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 712
- Immunology 787
- Biological Psychiatry 84
- Oncology 664
- Cancer Research 198
Countries citing papers authored by Brian Gardner
This map shows the geographic impact of Brian Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gardner more than expected).
Fields of papers citing papers by Brian Gardner
This network shows the impact of papers produced by Brian Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gardner. The network helps show where Brian Gardner may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 413 | |
| 2 | 2000 | 397 | |
| 3 | 2000 | 215 | |
| 4 | 1999 | 188 | |
| 5 | 2002 | 124 | |
| 6 | 2004 | 122 | |
| 7 | 2002 | 110 | |
| 8 | 2005 | 55 | |
| 9 | 2002 | 47 | |
| 10 | 2008 | 46 | |
| 11 | 2011 | 46 | |
| 12 | 2008 | 41 | |
| 13 | 2003 | 37 | |
| 14 | 2015 | 35 | |
| 15 | 2003 | 35 | |
| 16 | 2005 | 32 | |
| 17 | 2003 | 31 | |
| 18 | Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. | 2002 | 27 |
| 19 | 2016 | 17 | |
| 20 | Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. | 2013 | 15 |
About Brian Gardner
Brian Gardner is a scholar working on Molecular Biology, Pharmacology, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 27 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Cannabis and Cannabinoid Research (3 papers), Immune Cell Function and Interaction (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Immunotherapy and Immune Responses (3 papers), Estrogen and related hormone effects (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Pharmacology (712 citations), Immunology (787 citations), Biological Psychiatry (84 citations), Oncology (664 citations) and Cancer Research (198 citations). Brian Gardner has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Sherven Sharma, Steven M. Dubinett, Li Zhu, Raj K. Batra, Karen L. Reckamp, Marina Stolina, Ying Lin, Patrice W. Miller, Mitchell Kronenberg and Mariam Dohadwala. Their work appears in journals such as The Journal of Immunology, Journal of Thoracic Oncology, Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.